AFFINIA THERAPEUTICS
DEAD

Serial Number

98383243

Owner

Affinia Therapeutics Inc.

Attorney

John Paul Oleksiuk

First Use Date

Mar 31, 2020

Filing Date

Jan 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AFFINIA THERAPEUTICS Trademark

Serial Number: 98383243

AFFINIA THERAPEUTICS is a trademark filed by Affinia Therapeutics Inc. on January 30, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Affinia Therapeutics Inc. (12 trademarks)

43 Foundry Avenue, Suite 120
Waltham, MA 02453

Entity Type: 03

Trademark Details

Filing Date

January 30, 2024

Registration Date

Not Registered

First Use Anywhere

March 31, 2020

First Use in Commerce

March 31, 2020

Goods & Services

Research and development of pharmaceutical injectables and preparations, namely, vectors and preparations for gene therapy; provision of scientific research information in the field of adeno-associated virus (AAV) vectors and preparations for gene therapy; pharmaceutical engineering services, namely, pharmaceutical products development of vectors and gene therapy pharmaceutical preparations; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 14, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 14, 2026 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 28, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 28, 2026 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 29, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 29, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 29, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 11, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 11, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 11, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jun 11, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 12, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 11, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 11, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 11, 2025 CNSL
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 12, 2025 CHAN
ASSIGNED TO LIE
Feb 12, 2025 ALIE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 6, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 6, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 6, 2025 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 9, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 9, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 7, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2024 NWOS
NEW APPLICATION ENTERED
Jan 30, 2024 NWAP